To investigate the effect of low-dose heparin treatment beginning on the second, fourth, or tenth day in patients with spontaneous intracerebral hemorrhage.
- Heparin (acute stroke) Drug
Intervention Desc: Intravenous anticoagulant.
Randomized, controlled trial of 68 patients.
Patients were randomized to receive low-dose heparin (3 x 5000 units heparin-sodium/day sc) beginning on either the tenth day of treatment (group 1), the fourth day (group 2) or the second day (group 3). Group 1 served as the control group because heparin treatment beginning on day 10 of treatment was the standard treatment protocol in the intensive care unit. All patients received basic intensive care medication and regular diagnostic evaluations.
|Type||Measure||Time Frame||Safety Issue|
|Primary||Incidence of pulmonary embolism, deep-vein thrombosis and rebleeding after 10 days of treatment.|